脂蛋白 (a) 是血液透析患者心血管疾病的独立风险因素
M D Cressman1, R J Heyka, E P Paganini
1Department of Heart and Hypertension Research, Cleveland Clinic Foundation, OH 44195-5069.
Circulation
|August 1, 1992
概括
升高的脂蛋白 (Lp) 是血液透析患者动脉样硬化心血管事件的独立危险因素. 这项研究证实Lp (a) 是这种高风险人群中临床事件的重要预测因子.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床化学 临床化学
背景情况:
- 血清脂蛋白 (Lp) 是已知的动脉样硬化风险因素.
- 在血液透析患者中,Lp (a) 水平升高.
- 以前,血液透析患者的Lp(a) 与临床事件之间的关联尚未确立.
研究的目的:
- 确定Lp (a) 水平与与动脉样硬化相关的临床事件风险之间的关联.
- 调查慢性血液透析患者的Lp(a) 作为一个独立的风险因素.
主要方法:
- 对129名门诊血液透析患者进行前性研究.
- 放射性免疫试验测量了基线Lp (a) 水平.
- 进行48个月的随访,以评估可能发生动脉样硬化病因的临床事件.
主要成果:
- 与对照组相比,血液透析患者的中位数Lp (a) 水平显著更高.
- 基线Lp(a) 度是随访期间临床事件的重要预测指标.
- Lp (a) 和先前的临床事件是未来风险的唯一独立因素.
结论:
- 血清Lp (a) 是动脉样硬化心血管疾病事件的独立风险因素.
- 这一发现对接受慢性血液透析治疗的患者来说很重要,因为他们患有末期脏疾病.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...


